P r a w n - F r e s h ™

P ra w n -F re s h ™
MATERIAL SAFETY DATA SHEET
XyRex® Ltd.
65 Rodney St
Glasgow G4 9SQ
www.xyrex.com
1. P r o d u c t a n d C o m p a n y In fo rm a tio n
®
P ro d u c t Id e n tific a tion / T ra d e N a m e : X y R e x P r a w n - F r e s h
A p p lic a tio n:
T o p re v en t m e la n o s is , c o n tro l b a c te ria a n d e x te n d s h e lf life s afe ly an d
natu ra lly, w itho ut the n e ed fo r s o d iu m m e ta -b is u lp h ite .
®
Co m pan y:
E m e rg e n c y P ho n e :
Is s u e d B y:
R e s p o n s ib le P e rs o n:
X yR e x L td
+ 4 4 (0)7712525413
John Davis
2 . C o m p o s itio n
Th e pro du ct is a liquid b len d of n on -ha z ard ou s fo od g rad e o rga n ic a c ids, ino rg a n ic b uffers n atu ra l p la n t extra cts and
antioxidants.
1
2
3
Nam e
N on -h a z a rd o u s polyphenols and
poly-phenol derivitives
O ther n o n -h a z a rd o u s o rg a n ic a nd
inorg anic ac ids a n d s a lts
C AS
N /R
C o n c e n tra tio n
5 -8 % w /w
C la s s ific a tio n
Ref point 9
N /R
15 -1 8 % w /w
Ref point 9
E 586 antioxidant (nature identical)
136-77-6
8-12% w/w
Ref point 9
3. Ha z a rd Id e n tifi c a tio n
T h e M a in h a z a rd :
M a y c a u s e s light irritation to e ye
H ealth Classification : N o n e
F ire C la s s ification :
none
4 . F ir s t A id / E m e r g e n c y A c tio n s
If th is h a p p e n s
P ro d u c t
P ro d u c t
P ro d u c t
P ro d u c t
o n S k in :
in E ye s :
In g e s te d :
In h a le d :
© X y R e x ® L td 2 0 0 5
D o th is
B rie f or o c c a s io n a l c on ta c t is u n lik e ly to h a v e a s ig n ific an t e ffe c t.
R in s e w ith p le n ty of w ater for at le a s t 1 0 m in ute s .
W a s h ou t m o uth w ith w a te r. E s s e n tia lly n o n -to x ic
U n lik e ly to o c c ur
pag e 1 of 3
The technical information and suggestions for use contained herein are believed to be reliable, but they are not to be construed as warranties
and no patent liability can be assumed.
P ra w n -F re s h ™
5 . F ir e F ig h tin g M e a s u re s
F ire H a z a r d :
E x tin g u is h in g M e d ia :
S p e c ia l P ro t e c ti ve
E q u ip m e n t:
O th e r In fo r m a tio n :
N on -fla m m a b le
6 . A c c id e n ta l R e le a s e o r S p illa g e
P e rs o n a l P r e c a u tio n s :
E n vir o n m e n t a l
P re c a u t io n s :
M e th o d s fo r c le a n -u p :
O th e r In fo r m a tio n :
U s e p ro te c tiv e e qu ip m e nt
F lu s h w ith c o p io u s a m o u n ts of w a te r.
7 . H a n d lin g a n d S to ra g e
H a n d lin g a n d S to ra g e
M a te r ia ls :
H a n d lin g a n d S to ra g e
P re c a u t io n s :
none
S to re in a c o o l, d r y a tm o s p he re, in clo s ed c o n ta in e rs a nd at a m b ie nt
te m p e ra tu re to m a inta in s h e lf life.
8. P e rs o n a l P r o te c tio n & E x p o s u re C o n t r o l
P ro te c tive E q u ip m e n t:
R e s p ira to r y P r o t e c tio n :
E x p o s u r e C o n tr o l:
N on -H a z a rd o u s
N on -H a z a rd o u s
9 . P h y s ic a l a n d C h e m ic a l P ro p e r tie s
O d ou r:
A p p ea ra n c e :
D e n sity (k g /m 3 ):
S lig h t c itru s .
pa le b ro w n m ilk y liq u id .
112 0 @ 2 0 o C
o
M e ltin g P o int ( C ):
o
o
< - 10 C
B o iling P o int ( C ):
100
pH (c o n c e ntra te)
pH (1 % s o lu tio n)
1.2
1.5
D e c o m poo s
FTla
s hition
int): ( C ):
do e s n ot fla s h
em
p.P(oo C
A u to Ig n itio n T e m p .
( o C ):
n.d
U pper F la m m a b le
L im it:
Lo w er F la m m a b le
n.d
L im it:
S o lu b ility :
F u ll w a ter d is p e rs ib le.
V is c o s ity (c p s ):
.
10. S ta b ili ty a n d R e a c ti vit y
S ta b ility:
In c o m p a tib ilit y:
H a z a r d o u s D e c o m p o s itio n
P ro d u c ts :
© X y R e x ® L td 2 0 0 5
S ta b le u n der n o r m a l a m b ie n t c on d itio n s .
N o s ig n ific a nt in c o m p a tib ilitie s . D o no t s to re in c a rb o n s te e l.
none
page 2 of 3
The technical information and suggestions for use contained herein are believed to be reliable, but they are not to be construed as warranties
and no patent liability can be assumed.
P ra w n -F re s h ™
1 1 . T o x ic o lo g ic a l In fo r m a tio n
H e a lth E ffe c ts :
O n S k in :
O n E ye s :
O n In g e s tio n :
O n In h a la tio n :
C a n c e r:
C h r o n ic E ffe c ts :
O th e r T o x ic o lo g ic a l
In fo rm a tio n :
U n lik e ly to o c c u r.
M a y c a u s e irrita tio n after p ro lo ng e d or re p ea ted e x p o s u re .
N o s ig n ific a nt e ffe c ts a re lik e ly.
U n lik e ly to o c c u r.
T h e p ro d u c t c on ta ins n o k n o w n c a rc in o g e n s .
N ot d ete rm in e d.
1 2 . E c o lo g ic a l In fo r m a tio n
P ro d u c t w ill n ot b io a c c u m u la te.
B io d e g ra da tio n : A ll o rg a n ic in g re d ien ts a re b io d e g ra d a b le .
1 3 . D is p o s a l
D is p o s e o f la rg e qu a n titie s b y c o lle c tin g a s m u c h as p o s s ib le in a c lean c o n ta in er and m o v ing to a
s a fe p la c e for d is p o s a l. S m a ll re s id u e s c an b e a b s o rb e d in to s a n d or e a rth . D is p o s e o f a c c o rd in g to
lo c al re g u la tio n s .
1 4 . T ra n s p o rt In fo r m a tio n
P ro per S h ip p in g N a m e : N o t regu la te d .
T ra d e N a m e : X y R e x
®
P ra w n -F re s h .
A R D /R ID
C la s s :
U N N u m b e r:
P a c k ing G roup
H a z a rd Id en tific a tio n N u m b e r:
E m e rg e n c y A c tion C o d e (U K ):
IM D G
C la s s :
U N N u m b e r:
P a c k ing G roup :
M a rin e P o llu tan t:
E MS No :
M F A G T a b le N o :
T re m c a rd N o :
IA T A
C la s s :
S u b s id ia ry R is k s :
N ot re s tric ted
N ot re s tric ted
N ot re s tric te d
15. R e g u la to ry L a b e lli n g In fo r m a tio n
C la s s ific a tion :
N ot c la s s ifie d.
R is k P h ra s e s :
S a fe ty P h ra s e s :
1 6 . O th e r In fo r m a tio n :
D o c u m e n t N o .: 2 0 2 0
D ate of Is s ue : 5 T H May 2009.
© X y R e x ® L td 2 0 0 5
page 3 of 3
The technical information and suggestions for use contained herein are believed to be reliable, but they are not to be construed as warranties
and no patent liability can be assumed.